Pseudotumoural presentation of neuro-behçet's disease: Case series and review of literature

Rheumatology (United Kingdom)

Volumn 51, Issue 7, 2012, Pages 1216-1225

  Noel, Nicolas ^a   Hutié, Marie ^a   Wechsler, Bertrand ^a   Vignes, Stéphane ^a   Le Thi Huong Boutin, Du ^a   Amoura, Zahir ^a   Dormont, Didier ^a   Delcey, Véronique ^b   Polivka, Marc ^b   Cacoub, Patrice ^a   Saadoun, David ^a  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b HÔPITAL LARIBOISIÈRE   (France)

Author keywords

Beh et's syndrome; Neurological manifestations; Vasculitis

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; STEROID;

ADULT; ARTICLE; BEHCET DISEASE; CEREBELLUM DISEASE; CONTROLLED STUDY; DISABILITY; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HEADACHE; HISTOLOGY; HUMAN; LITERATURE; MAJOR CLINICAL STUDY; MALE; NECROSIS; NEUROIMAGING; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PSEUDOBULBAR PALSY; PSEUDOTUMOR; RANKIN SCALE; REMISSION; SPHINCTER; TREATMENT OUTCOME;

ADULT; BEHCET SYNDROME; BIOPSY; BRAIN; DIAGNOSIS, DIFFERENTIAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NERVOUS SYSTEM DISEASES; PSEUDOTUMOR CEREBRI; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84863845132     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ker449     Document Type: Article

References (42)

1. International Study Group for Behçet's Disease. Criteria for diagnosis of Behçet's disease. Lancet 1990;335: 1078-80.
2. Akman-Demir G, Serdaroglu P, Tasçi B. Clinical patterns of neurological involvement in Behçet's disease: evaluation of 200 patients. The Neuro-Behçet Study Group. Brain 1999;122:2171-82.
3. Ideguchi H, Suda A, Takeno M et al. Neurological manifestations of Behçet's disease in Japan: a study of 54 patients. J Neurol 2010;257:1012-20.
4. Siva A, Kantarci OH, Saip S et al. Behçet's disease: diagnostic and prognostic aspects of neurological involvement. J Neurol 2001;248:95-103.
5. Riera-Mestre A, Martínez-Yelamos S, Martínez-Yelamos A et al. Clinicopathologic features and outcomes of neuro-Behçet disease in Spain: a study of 20 patients. Eur J Intern Med 2010;21:536-41.
6. Al-Araji A, Kidd DP. Neuro-Behçet's disease: epidemiology, clinical characteristics, and management. Lancet Neurol 2009;8:192-204.
7. Saadoun D, Wechsler B, Resche-Rigon M et al. Cerebral venous thrombosis in Behçet's disease. Arthritis Rheum 2009;61:518-26.
8. O'Duffy J. Suggested criteria for diagnosis of Behçet's disease. J Rheumatol 1974;1:18.
9. Vignes S, Vidailhet M, Dormont D et al. [Pseudotumorous presentation of neuro-Behçet: role of the withdrawal of colchicine?]. Rev Med Interne 1998;19:55-9.
10. Can E, Kara B, Somer A et al. Neuro-Behçet disease presenting as secondary pseudotumor syndrome: case report. Eur J Paediatr Neurol 2006;10:97-9.
11. Litvan I, Roig C, Rovira A et al. Behçet's syndrome masquerading as tumor. Neuroradiology 1987;29:103.
12. Kermode AG, Plant GT, MacManus DG et al. Behçet's disease with slowly enlarging midbrain mass on MRI: resolution following steroid therapy. Neurology 1989;39: 1251-2.
13. Neudorfer M, Feiler-Ofri V, Geyer O et al. Behçet's disease presenting as a cerebral tumour. Neuroradiology 1993;35: 145.
14. Geny C, Cesaro P, Heran F et al. Pseudotumoral neuro-Behçet's disease. Surg Neurol 1993;39:374-76.
15. Dupin M, Zimmermann R, Flocard F et al. [Neuro-Behçet disease with solitary cerebral pseudotumor disclosed by headaches]. Ann Med Interne 1996;147:524-6.
16. Imoto H, Nishizaki T, Nogami K et al. Neuro-Behçet's disease manifesting as a neoplasm-like lesion-case report. Neurol Med Chir 2002;42:406-9.
17. Yoshimura J, Toyama M, Sekihara Y et al. [Neuro-Behcet disease mimicking a thalamic tumor]. No Shinkei Geka 2001;29:527-31.
18. Ben Taarit C, Turki S, Ben Maïz H. [Pseudotumoral neurobehçet: a case report]. J Mal Vasc 2002;27:93-5.
19. Park J-H, Jung M-K, Bang C-O et al. Neuro-Behçet's disease mimicking a cerebral tumor: a case report. J Korean Med Sci 2002;17:718-22.
20. Tuzgen S, Kaya AH, Erdincler D et al. Two cases of neuro-Behcet's disease mimicking cerebral tumor. Neurol India 2003;51:376-8.
21. Darmoul M, Habib Bouhaouala M, Smida H et al. [Pseudo-tumoral neuro-Behçet's disease]. Rev Neurol 2006;162:643-7.
22. Schmolck H. Large thalamic mass due to neuro-Behcet disease. Neurology 2005;65:436.
23. Bennett DLH, McCabe DJH, Stevens JM et al. Tumefactive neuro-Behcet disease. Neurology 2004;63:709.
24. Matsuo K, Yamada K, Nakajima K et al. Neuro-Behçet disease mimicking brain tumor. AJNR Am J Neuroradiol 2005;26:650-3.
25. Appenzeller S, de Castro R, Queiroz Lde S et al. Brain tumor-like lesion in Behçet disease. Rheumatol Int 2006; 26:577-80.
26. Heo J-H, Lee S-T, Chu K et al. Neuro-Behcet's disease mimicking multiple brain tumors: diffusion-weighted MR study and literature review. J Neurol Sci 2008;264:177-81.
27. Varoglu AO. A case of Neuro-Behcet disease mimicking gliomatosis cerebri. AJNR Am J Neuroradiol 2010;31:E1.
28. Koçer N, Islak C, Siva A et al. CNS involvement in neuro-Behçet syndrome: an MR study. AJNR Am J Neuroradiol 1999;20:1015-24.
29. Meguro A, Inoko H, Ota M et al. Genetics of Behçet disease inside and outside the MHC. Ann Rheum Dis 2010; 69:747-54.
30. Joseph FG, Scolding NJ. Neuro-Behçet's disease in Caucasians: a study of 22 patients. Eur J Neurol 2007;14: 174-80.
31. Liozon E, Roussin C, Puéchal X et al. Behçet's disease in East African patients may not be unusual and is an HLA-B51 negative condition: a case series from Mayotte (Comoros). Joint Bone Spine 2011;78:166-70.
32. Borhani Haghighi A, Sarhadi S, Farahangiz S. MRI findings of neuro-Behcet's disease. Clin Rheumatol 2011;30: 765-70.
33. Arai Y, Kohno S, Takahashi Y et al. Autopsy case of neuro-Behçet's disease with multifocal neutrophilic perivascular inflammation. Neuropathology 2006;26:579-85.
34. Hirohata S. Histopathology of central nervous system lesions in Behçet's disease. J Neurol Sci 2008;267:41-7.
35. Hamuryudan V, Ozyazgan Y, Hizli N et al. Azathioprine in Behcet's syndrome: effects on long-term prognosis. Arthritis Rheum 1997;40:769-74.
36. Yazici H, Pazarli H, Barnes CG et al. A controlled trial of azathioprine in Behçet's syndrome. N Engl J Med 1990; 322:281-5.
37. Hirohata S, Suda H, Hashimoto T. Low-dose weekly methotrexate for progressive neuropsychiatric manifestations in Behcet's disease. J Neurol Sci 1998; 159:181-5.
38. Kikuchi H, Aramaki K, Hirohata S. Low dose MTX for progressive neuro-Behçet's disease. A follow-up study for 4 years. Adv Exp Med Biol 2003;528: 575-8.
39. Du LT, Fain O, Wechsler B et al. [Value of " bolus" cyclophosphamide injections in Behçet's disease. Experience of 17 cases]. Presse Med 1990;19:1355-8.
40. Hamza M, Meddeb S, Mili I et al. [Bolus of cyclophosphamide and methylprednisolone in uveitis in Behçet's disease. Preliminary results with the use of new criteria of evaluation]. Ann Med Interne 1992;143:438-41.
41. Sfikakis PP, Markomichelakis N, Alpsoy E et al. Anti-TNF therapy in the management of Behcet's disease-review and basis for recommendations. Rheumatology 2007;46: 736-41.
42. Hatemi G, Silman A, Bang D et al. Management of Behçet disease: a systematic literature review for the European League against Rheumatism evidence-based recommendations for the management of Behçet disease. Ann Rheum Dis 2009;68:1528-34.